Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
Open accessAbstract
// Liping Wang 1, 2, * , Zhufang Tian 2, * , Qi Yang 1 , Heng Li 2 , Haixia Guan 3 , Bingyin Shi 1 , Peng Hou 1 , Meiju Ji 4 1 Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China 2 Department of Endocrinology, Xi'an Central Hospital, Xi'an 710003, P.R. China 3 Department of Endocrinology and Metabolism, The First Affiliated Hospital of China Medical University, Shenyang 110001, P.R. China 4 Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an 710061, P.R. China * These authors have contributed equally to this work Correspondence to: Peng Hou, e-mail: phou@mail.xjtu.edu.cn Meiju Ji, e-mail: mjji0409@163.com Keywords: thyroid cancer, sulforaphane (SFN), reactive oxygen species (ROS), signaling pathways Received: March 12, 2015 Accepted: July 06, 2015 Published: July 17, 2015 ABSTRACT Sulforaphane (SFN), a natural compound derived from broccoli/broccoli sprouts, has been demonstrated to be used as an antitumor agent in different types of cancers. However, its antitumor effect in thyroid cancer remains largely unknown. The aim of the study was to investigate the therapeutic potential of SFN for thyroid cancer and explore the mechanisms underlying antitumor effects of SFN by in vitro and in vivo studies. Our data demonstrated that SFN significantly inhibited thyroid cancer cell proliferation in a dose- and time-dependent manner, induced G2/M phase cell cycle arrest and apoptosis, and inhibited thyroid cancer cell migration and invasion by suppressing epithelial-mesenchymal transition (EMT) process and expression of Slug , Twist , MMP-2 and -9 . Mechanically, SFN inhibited thyroid cancer cell growth and invasiveness through repressing phosphorylation of Akt, enhancing p21 expression by the activation of Erk and p38 signaling cascades, and promoting mitochondrial-mediated apoptosis via reactive oxygen species (ROS)-dependent pathway. Growth of xenograft tumors derived from thyroid cancer cell line FTC133 in nude mice was also significantly inhibited by SFN. Importantly, we did not find significant effect of SFN on body weight and liver function of mice. Collectively, we for the first time demonstrate that SFN is a potentially effective antitumor agent for thyroid cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Approximately 5-15% of PTC cases are DePTC, associated with poor prognosis and high early-mortality.
“Nevertheless, approximately 5-15% of the cases are dedifferentiated papillary thyroid cancer (DePTC), which is associated with poor prognosis and high early-mortality [7–9].”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499 · see citing works
Reitman, S., & Frankel, S. (1957) · American Journal of Clinical Pathology · doi:10.1093/ajcp/28.1.56 · Cited by 10,015 · see citing works
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., & Earnshaw, W. C. (1994) · Nature · doi:10.1038/371346a0 · Cited by 2,563 · see citing works
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312 · see citing works
Molecular pathogenesis and mechanisms of thyroid cancer
Xing, M. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3431 · Cited by 1,433 · see citing works
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,353 · see citing works
Larue, L., & Bellacosa, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209091 · Cited by 1,221 · see citing works
Molecular genetics and diagnosis of thyroid cancer
Nikiforov, Y. E., & Nikiforova, M. N. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.142 · Cited by 1,012 · see citing works
The mitochondrial pathways of apoptosis
Estaquier, J., Vallette, F., Vayssiere, J.-L., & Mignotte, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_7 · Cited by 637 · see citing works
Shapiro, T. A., Fahey, J. W., Dinkova‐Kostova, A. T., Holtzclaw, W. D., Stephenson, K. K., Wade, K. L., Ye, L., & Talalay, P. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_7 · Cited by 330 · see citing works
Myzak, M. C., Hardin, K., Wang, R., Dashwood, R. H., & Ho, E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi265 · Cited by 307 · see citing works
Jeong, W., Kim, I., Hu, R., & Kong, A. T. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022413.43212.cf · Cited by 264 · see citing works
The Role of Matrix Metalloproteinases in Tumor Invasion, Metastasis, and Angiogenesis
Stetler‐Stevenson, W. G. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30071-1 · Cited by 240 · see citing works
Fimognari, C. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.581 · Cited by 237 · see citing works
Fenouille, N., Tichet, M., Dufies, M., Pottier, A., Mogha, A., Soo, J. K., Rocchi, S., Mallavialle, A., Galibert, M., Khammari, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040378 · Cited by 230 · see citing works
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer
Alumkal, J. J., Slottke, R., Schwartzman, J. A., Cherala, G., Munar, M. Y., Graff, J. N., Beer, T. M., Ryan, C. W., Koop, D. R., Gibbs, A., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0189-z · Cited by 224 · see citing works
Jackson, S. J. T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg192 · Cited by 189 · see citing works
Cossarizza, A., Ferraresi, R., Troiano, L., Roat, E., Gibellini, L., Bertoncelli, L., Nasi, M., & Pinti, M. (2009) · Nature Protocols · doi:10.1038/nprot.2009.189 · Cited by 182 · see citing works
Clarke, J., Hsu, A., Yu, Z., Dashwood, R. H., & Ho, E. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000547 · Cited by 179 · see citing works
Xu, C., Shen, G., Yuan, X., Kim, J. H., Gopalkrishnan, A., Keum, Y., Nair, S., & Kong, A. T. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi251 · Cited by 175 · see citing works
Hu, R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl049 · Cited by 163 · see citing works
Pham, N., Jacobberger, J. W., Schimmer, A. D., Cao, P. M., Gronda, M., & Hedley, D. W. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1239.3.10 · Cited by 151 · see citing works
Role of reactive oxygen species and MAPKs in vanadate-induced G2/M phase arrest
Zhang, Z., Leonard, S. S., Huang, C., et al. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00145-x · Cited by 142 · see citing works
Shankar, S., Ganapathy, S., & Srivastava, R. K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0903 · Cited by 133 · see citing works
Vanadate-Induced Cell Growth Regulation and the Role of Reactive Oxygen Species
Zhang, Z., Huang, C., Li, J., Leonard, S. S., Lanciotti, R. S., Butterworth, L. F., & Shi, X. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2464 · Cited by 130 · see citing works
Shankar, S., Ganapathy, S., & Srivastava, R. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3596 · Cited by 121 · see citing works
Leontieva, O. V., & Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100402 · Cited by 101 · see citing works
Xiao, D., Powolny, A. A., Antosiewicz, J., Hahm, E., Bommareddy, A., Zeng, Y., Desai, D. H., Amin, S., Herman-Antosiewicz, A., & Singh, S. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9883-5 · Cited by 97 · see citing works
Anaplastic thyroid carcinoma: An overview
Cornett, W. R., Sharma, A. K., Day, T. A., et al. (2007) · Current Oncology Reports · doi:10.1007/s11912-007-0014-3 · Cited by 92 · see citing works
Choi, W. Y., Choi, B. T., Lee, W. H., & Choi, Y. H. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.001 · Cited by 89 · see citing works
[2] Determination of median lethal and infectious doses in animal model systems
Welkos, S. L., & O'Brien, A. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)35128-7 · Cited by 80 · see citing works
Park, H. S., Han, M. H., Kim, G., Moon, S., Kim, W., Hwang, H. J., Park, K. Y., & Choi, Y. H. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.11.034 · Cited by 76 · see citing works
Chung, Y. W., Jeong, D.-W., Won, J. Y., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00360-1 · Cited by 64 · see citing works
Yang, Q., Ji, M., Guan, H., Shi, B., & Hou, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2583 · Cited by 58 · see citing works
Self-citationQiang, W., Zhao, Y., Yang, Q., Liu, W., Guan, H., Lv, S., Ji, M., Shi, B., & Hou, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3729 · Cited by 48 · see citing works
Self-citationInduction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells
Purayil, H. T., Thejass, P., & Kuttan, G. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2010.538694 · Cited by 45 · see citing works
Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma
Voigt, W., Kegel, T., Weiss, M., et al. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0673-0 · Cited by 41 · see citing works
Rudolf, E., & Červinka, M. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.04.019 · Cited by 38 · see citing works
Bergantin, E., Quarta, C., Nanni, C., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29684 · Cited by 28 · see citing works
Landriscina, M., Maddalena, F., Fabiano, A., Piscazzi, A., Macchia, O. L., & Cignarelli, M. (2010) · PubMed · Cited by 26 · see citing works
Deutschbein, T., Matuszczyk, A., Moeller, L. C., et al. (2011) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0031-1279704 · Cited by 16 · see citing works
Medical Therapy for Advanced Forms of Thyroid Cancer
Rajhbeharrysingh, U., Taylor, M. H., & Milas, M. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.03.003 · Cited by 11 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- [2]Howlader N Noone AM Krapcho M Garshell J Miller D Altekruse SF Kosary CL Yu M Ruhl J Tatalovich Z Mariotto A Lewis DR Chen HS SEER Cancer Statistics Review, 1975–2011 National Cancer Institute Bethesda, MD http://seer.cancer.-gov/csr/1975_2011/. based on November 2013 SEER data submission, posted to the SEER website, April 2014
- [18]Estaquier J Vallette F Vayssiere JL Mignotte B The mitochondrial pathway of apoptosis Adv Exp Med Biol 2012 942 157 183 22399422
- [24]Fimognari C Nüsse M Cesari R Iori R Cantelli-Forti G Hrelia P Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane Carcinogenesis 2002 23 581 586 11960909
- [26]Choi WY Choi BT Lee WH Choi YH Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells Biomed Pharmacother 2008 62 637 644 18313257
Cited by
Sorted by citations
Liang, J., Hänsch, G. M., Hübner, K., & Samstag, Y. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.11.006 · Cited by 72 · see citing works
Chen, H., Luo, D., Zhang, L., Lin, X., Luo, Q., Yi, H., Wang, J., Yan, X., Li, B., Chen, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17398 · Cited by 29 · see citing works
- Authors
- Wang, L., Tian, Z., Yang, Q., Li, H., Guan, H., Shi, B., Hou, P., & Ji, M.
- Affiliations
- Xian Central Hospital (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- First Hospital of China Medical University (CN)
- Corresponding author
- Wang, Liping
- Tian, Zhufang
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-07-17
- Volume
- 6
- Issue
- 28
- Pages
- 25917-25931
- ISSN
- 1949-2553 (ISSN-L)
- PMC
- PMC4694875
- OpenAlex
- W1937142939
- Cited by
- 69
- References
- 42
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 10 · 2018: 13 · 2017: 7 · 2016: 10
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Oncotarget (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81372217, 81272933, 81472622, 81402340)
- Ministry of Education of the People's Republic of China
- Fundamental Research Funds for the Central Universities
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Keywords
- sulforaphane, thyroid cancer, reactive oxygen species, cell proliferation, cell invasion, epithelial-mesenchymal transition, Slug, Twist, MMP-2, MMP-9, Akt phosphorylation, p21, ERK signaling, p38 signaling, mitochondrial apoptosis, tumor xenografts, broccoli sprouts, chemoprevention, cell cycle arrest
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Female, Humans, Mice, Nude, Neoplasm Invasiveness, Sulfoxides, Thyroid Neoplasms, Time Factors, Tumor Cells, Cultured, Blotting, Western, Signal Transduction, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Reactive Oxygen Species, Isothiocyanates, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, Xenograft Model Antitumor Assays, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Apoptosis Regulatory Proteins, Membrane Potential, Mitochondrial, Cell Cycle Checkpoints
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
